Journal of the American Academy of Child & Adolescent Psychiatry
New ResearchNational Comorbidity Survey Replication Adolescent Supplement (NCS-A): III. Concordance of DSM-IV/CIDI Diagnoses With Clinical Reassessments
Section snippets
NCS-A Sample
The NCS-A is a nationally representative face-to-face survey of 10,148 adolescents (aged 13–17 years) in the continental United States performed between February 2001 and January 2004 in a dual-frame sample that included a household subsample and a school subsample. The household subsample consisted of adolescent residents of the households that participated in the National Comorbidity Survey Replication (NCS-R), a nationally representative household survey of adults.28 This subsample was
Aggregate Concordance
It should be noted that the prevalence estimates presented here are not identical to the NCS-A prevalence estimates. Instead, they represent best estimates in the clinical reappraisal sample based on an attempt to weight the latter sample as best we could to represent the larger sample. There are inevitable limitations to this weighting procedure, however, based on the small size of the clinical reappraisal sample. Within the context of these limitations, the McNemar tests of CIDI versus K-SADS
Discussion
Before turning to substantive interpretation, a number of methodological limitations must be acknowledged. First, K-SADS interviews were performed by telephone, and CIDI interviews were performed face-to-face. Although telephone interviews constitute a valid mode of clinical assessment in both adults29, 30 and adolescents,31, 32 we do not know what would have happened if the same mode of administration had been used in both interviews. Second, the design of the clinical reappraisal study, in
References (66)
- et al.
Criterion validity of the NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3)
J Am Acad Child Adolesc Psychiatry
(1996) - et al.
Reliability, validity, and parent-child agreement studies of the Diagnostic Interview for Children and Adolescents (DICA)
J Am Acad Child Adolesc Psychiatry
(1987) - et al.
The National Comorbidity Survey Replication Adolescent Supplement (NCS-A): I. Background and Measures
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
The National Comorbidity Survey Replication Adolescent Supplement (NCS-A): II. Overview and design
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data
J Am Acad Child Adolesc Psychiatry
(1997) Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review
J Psychiatr Res
(1994)- et al.
Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder
J Psychiatr Res
(1995) - et al.
Bias, prevalence and kappa
J Clin Epidemiol
(1993) - et al.
Measures of clinical significance
J Am Acad Child Adolesc Psychiatry
(2003) - et al.
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
Biol Psychiatry
(2003)
The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication
Biol Psychiatry
DSM-IV personality disorders in the National Comorbidity Survey Replication
Biol Psychiatry
Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders
Drug Alcohol Depend
Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS)
J Am Acad Child Adolesc Psychiatry
The Child and Adolescent Psychiatric Assessment (CAPA)
J Am Acad Child Adolesc Psychiatry
Diagnosing depression in the medically ill: validity of a lay-administered structured diagnostic interview
J Psychiatr Res
Psychiatric diagnosis: are clinicians still necessary?
Compr Psychiatry
Comparing DISC-IV and clinician diagnoses among youths receiving public mental health services
J Am Acad Child Adolesc Psychiatry
Comparing the validity of clinician-generated diagnosis of conduct disorder to the diagnostic interview schedule for children
J Clin Child Adolesc Psychol
A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN)
Psychol Med
Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys
Int J Methods Psychiatr Res
Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates
Arch Gen Psychiatry
The Child and Adolescent Psychiatric Assessment (CAPA)
Psychol Med
Validity of the NIMH Diagnostic Interview Schedule for Children: a comparison between psychiatric and pediatric referrals
J Abnorm Child Psychol
Evaluation of the Diagnostic Interview for Children and Adolescents for use in general population samples
J Abnorm Child Psychol
Diagnostic agreement between clinicians and the Diagnostic Interview for Children and Adolescents—DICA-R—in an outpatient sample
J Child Psychol Psychiatry
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
Int J Methods Psychiatr Res
Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey
Int J Methods Psychiatr Res
Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders
Psychol Med
SCAN. Schedules for Clinical Assessment in Neuropsychiatry
Arch Gen Psychiatry
A comparison of two structured diagnostic interviews: CIDI and SCAN
Aust N Z J Psychiatry
Validation of two survey diagnostic interviews among primary care attendees: a comparison of CIS-R and CIDI with SCAN ICD-10 diagnostic categories
Psychol Med
Cited by (0)
The National Comorbidity Survey Replication Adolescent Supplement (NCS-A) is supported by the National Institute of Mental Health (NIMH; Grant U01-MH60220) with supplemental support from the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (Grant 044780), and the John W. Alden Trust. The work of Dr. Merikangas and her staff on the NCS-A is additionally supported by the NIMH Intramural Research Program, whereas the work of Dr. Zaslavsky and his staff on the validity of the NCS-A measures is supported by NIMH Grant R01-MH66627. The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or U.S. Government. A complete list of NCS-A publications can be found at http://www.hcp.med.harvard.edu/ncs.
The NCS-A is performed in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the staff of the WMH Coordination Centers for assistance with instrumentation, fieldwork, and consultation on data analysis. The WMH Data Coordination Centers have received support from NIMH (Grants R01-MH070884, R13-MH066849, R01-MH069864, and R01-MH077883), National Institute on Drug Abuse (Grant R01-DA016558), the Fogarty International Center of the National Institutes of Health (Grant R03-TW006481), the John D. and Catherine T MacArthur Foundation, the Pfizer Foundation, and the Pan American Health Organization. The WMH Data Coordination Centers have also received unrestricted educational grants from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Ortho-McNeil, Pfizer, Sanofi-Aventis, and Wyeth. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh.
The authors thank Steven Heeringa, Ph.D., and Alan Zaslavsky, Ph.D., as the statistical experts for this article.
This article is the subject of an editorial by Dr. Peter Szatmari in this issue.